牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

君实生物（688180）

5.1

综合诊断：5.1分打败了33%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
长期趋势：
已有363家主力机构披露2025-06-30报告期持股数据，持仓量总计2.72亿股，占流通A股35.53%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

5.6分

4.1分

5.5分

3.7分

5.7分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：5.6技术面打败了39%的股票技术面评分前10的股票

近期的平均成本为38.08元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

技术面得分最高的股票

平均成本

近期的平均成本为38.08元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"38.08","date":1762419747,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势跑输大盘，跑输行业平均水平。

[{"date":"2025.11.07","stock":"-1.92","trade":"-0.48","ind":"-0.25"},{"date":"2025.11.06","stock":"-0.75","trade":"-0.33","ind":"0.97"},{"date":"2025.11.05","stock":"-0.61","trade":"-0.81","ind":"0.23"},{"date":"2025.11.04","stock":"-2.96","trade":"-0.81","ind":"-0.41"},{"date":"2025.11.03","stock":"-0.30","trade":"0.04","ind":"0.55"},{"date":"2025.10.31","stock":"5.76","trade":"4.09","ind":"-0.81"},{"date":"2025.10.30","stock":"-2.03","trade":"-0.83","ind":"-0.73"},{"date":"2025.10.29","stock":"0.85","trade":"1.00","ind":"0.70"},{"date":"2025.10.28","stock":"-0.26","trade":"0.24","ind":"-0.22"},{"date":"2025.10.27","stock":"2.51","trade":"0.61","ind":"1.18"},{"date":"2025.10.24","stock":"0.72","trade":"0.39","ind":"0.71"},{"date":"2025.10.23","stock":"-2.67","trade":"-1.29","ind":"0.22"},{"date":"2025.10.22","stock":"-1.15","trade":"-0.28","ind":"-0.07"},{"date":"2025.10.21","stock":"0.83","trade":"1.45","ind":"1.36"},{"date":"2025.10.20","stock":"-0.34","trade":"0.44","ind":"0.63"},{"date":"2025.10.17","stock":"-0.21","trade":"-1.55","ind":"-1.95"},{"date":"2025.10.16","stock":"1.17","trade":"0.01","ind":"0.10"},{"date":"2025.10.15","stock":"2.02","trade":"2.13","ind":"1.22"},{"date":"2025.10.14","stock":"-3.19","trade":"-1.02","ind":"-0.62"},{"date":"2025.10.13","stock":"-1.77","trade":"-1.02","ind":"-0.19"},{"date":"2025.10.10","stock":"-3.53","trade":"-0.88","ind":"-0.94"}]

君实生物,上证指数,生物制品指数

压力支撑

该股压力位为38.11元，支撑位为37.63元。

[{"text":"\u538b\u529b\u4f4d","value":"38.11","date":1762444800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"37.63","date":1762444800,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.1资金面打败了43%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：11月07日 20:31

机构今日流向(万元)	-992.08	机构5日流向(万元)	-6847.91
机构10日流向(万元)	-4078.06	机构20日流向(万元)	-12662.03

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1988.85万股，其中基金净减仓79家，主力净增仓154家，请投资者中长期谨慎为宜。

截止2025-06-30，共363家主力机构（基金360家，一般法人3家），持仓量总计27167.21万股，占流通A股35.53%
其中，基金持仓与2024-12-31相比：
增仓：39家，增持 728.89万股
减仓：118家，减持 1533.58万股
新出现在主力名单中：193家，持有3001.26万股
从主力名单中消失：39家，原持有173.84万股

消息面诊股

诊断结果：5.5消息面打败了81%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向	公司购买资产	2025-09-30
一般消息	重大事项	关联交易	2025-09-30
一般消息	高管变动	因其他工作安排	2025-09-29
一般消息	募资投向		2025-09-19
一般消息	股东大会	临时股东大会	2025-09-16
一般消息	分红转增	不分配不转增	2025-08-27
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-06-30
一般消息	分红转增	不分配不转增	2025-03-28
利好	业绩预告	预计减亏	2025-01-18
利好	重大事项	参股拟上市公司或非上市公司金融机构	2024-12-31
一般消息	高管变动	其他工作安排	2024-12-20

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	0条	0条	0条

行业面诊股

诊断结果：3.7行业面打败了55%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2025.11.07","price":"-0.25","value":"-0.48"},{"date":"2025.11.06","price":"0.97","value":"-0.33"},{"date":"2025.11.05","price":"0.23","value":"-0.81"},{"date":"2025.11.04","price":"-0.41","value":"-0.81"},{"date":"2025.11.03","price":"0.55","value":"0.04"},{"date":"2025.10.31","price":"-0.81","value":"4.09"},{"date":"2025.10.30","price":"-0.73","value":"-0.83"},{"date":"2025.10.29","price":"0.70","value":"1.00"},{"date":"2025.10.28","price":"-0.22","value":"0.24"},{"date":"2025.10.27","price":"1.18","value":"0.61"},{"date":"2025.10.24","price":"0.71","value":"0.39"},{"date":"2025.10.23","price":"0.22","value":"-1.29"},{"date":"2025.10.22","price":"-0.07","value":"-0.28"},{"date":"2025.10.21","price":"1.36","value":"1.45"},{"date":"2025.10.20","price":"0.63","value":"0.44"},{"date":"2025.10.17","price":"-1.95","value":"-1.55"},{"date":"2025.10.16","price":"0.10","value":"0.01"},{"date":"2025.10.15","price":"1.22","value":"2.13"},{"date":"2025.10.14","price":"-0.62","value":"-1.02"},{"date":"2025.10.13","price":"-0.19","value":"-1.02"},{"date":"2025.10.10","price":"-0.94","value":"-0.88"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	万泽股份	44.57%	30.27%	7.0分
2	华兰疫苗	37.52%	5.69%	6.0分
3	三生国健	24.46%	-10.56%	6.3分
4	金迪克	12.67%	0.23%	5.5分
5	-	10.91%	-1.71%	分
6	我武生物	10.77%	-4.03%	5.2分
7	ST未名	8.28%	5.51%	5.5分
8	*ST四环	7.17%	3.25%	4.9分
9	通化东宝	6.90%	1.22%	6.2分
10	-	6.72%	-2.87%	分
11	赛升药业	5.95%	-4.25%	4.7分
12	安科生物	5.91%	0.18%	6.5分
13	*ST双成	5.70%	-1.92%	5.4分
14	沃森生物	5.68%	0.41%	5.5分
15	优宁维	4.79%	1.00%	6.0分
16	康华生物	4.71%	4.39%	6.4分
17	博晖创新	4.66%	1.39%	5.7分
18	赛伦生物	4.51%	-1.23%	6.0分
19	东宝生物	4.31%	4.31%	6.1分
20	华兰生物	4.24%	2.11%	6.1分
21	-	3.98%	-7.12%	分
22	近岸蛋白	2.16%	-3.12%	5.3分
23	卫光生物	1.77%	0.58%	5.9分
24	昊帆生物	1.48%	-7.37%	5.7分
25	康泰生物	1.25%	-1.45%	5.4分
26	义翘神州	1.24%	-1.82%	5.8分
27	上海莱士	1.18%	2.08%	6.6分
28	智飞生物	0.91%	2.48%	5.5分
29	诺唯赞	0.88%	-2.30%	6.0分
30	博雅生物	0.64%	-0.04%	6.3分
31	成大生物	0.48%	0.04%	5.5分
32	辽宁成大	-0.08%	0.55%	6.4分
33	凯因科技	-0.29%	-3.77%	5.4分
34	百克生物	-0.64%	-0.41%	5.5分
35	艾迪药业	-0.97%	-3.82%	6.1分
36	派林生物	-1.47%	1.97%	5.7分
37	诺诚健华	-1.77%	-2.73%	5.5分
38	百普赛斯	-2.61%	-7.67%	4.4分
39	智翔金泰	-2.65%	-4.39%	5.3分
40	康希诺	-2.66%	-6.18%	5.1分
41	君实生物	-4.59%	-6.39%	5.1分
42	天坛生物	-4.86%	-0.05%	5.7分
43	迈威生物	-4.99%	-10.55%	4.9分
44	西藏药业	-5.81%	-0.82%	6.2分
45	百奥泰	-5.87%	-5.73%	5.5分
46	荣昌生物	-5.88%	-12.29%	5.2分
47	科兴制药	-6.84%	-10.68%	5.6分
48	神州细胞	-8.57%	-7.06%	5.0分
49	康辰药业	-9.45%	-9.31%	5.3分
50	特宝生物	-10.35%	0.10%	6.4分
51	欧林生物	-10.95%	-8.61%	6.0分
52	甘李药业	-13.39%	-5.77%	5.2分
53	康弘药业	-13.50%	-7.95%	5.2分
54	长春高新	-23.33%	-6.91%	5.1分
55	禾元生物	-	-23.14%	4.4分

<上一页 1 2 3 4 5...10 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.7基本面打败了44%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，两项指标的行业排名分别为 45/72 ， 16/72。

[{"date":"2025-09-30","value":"-9.87","vol":"-9.95"},{"date":"2025-06-30","value":"-6.75","vol":"-0.61"},{"date":"2025-03-31","value":"-4.09","vol":"0.46"},{"date":"2024-12-31","value":"-19.69","vol":"-0.68"},{"date":"2024-09-30","value":"-13.91","vol":"1.34"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	-9.87	-6.75	-4.09	-19.69	-13.91
行业(%)	-9.95	-0.61	0.46	-0.68	1.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"80.65","vol":"67.19"},{"date":"2025-06-30","value":"80.06","vol":"68.28"},{"date":"2025-03-31","value":"81.24","vol":"68.43"},{"date":"2024-12-31","value":"78.92","vol":"69.85"},{"date":"2024-09-30","value":"74.41","vol":"70.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	80.65	80.06	81.24	78.92	74.41
行业(%)	67.19	68.28	68.43	69.85	70.47

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：尚可，接近行业平均，两项指标的行业排名分别为 8/72 ， 15/72。

[{"date":"2025-09-30","value":"42.06","vol":"44.96"},{"date":"2025-06-30","value":"48.64","vol":"6902.04"},{"date":"2025-03-31","value":"31.46","vol":"6125.27"},{"date":"2024-12-31","value":"29.67","vol":"47.35"},{"date":"2024-09-30","value":"28.87","vol":"175.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	42.06	48.64	31.46	29.67	28.87
行业(%)	44.96	6902.04	6125.27	47.35	175.00

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"35.72","vol":"44.17"},{"date":"2025-06-30","value":"36.01","vol":"5.44"},{"date":"2025-03-31","value":"17.01","vol":"-8.46"},{"date":"2024-12-31","value":"43.90","vol":"-9.81"},{"date":"2024-09-30","value":"34.12","vol":"-52.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	35.72	36.01	17.01	43.90	34.12
行业(%)	44.17	5.44	-8.46	-9.81	-52.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，两项指标的行业排名分别为 33/72 ， 29/72。

[{"date":"2025-09-30","value":"0.16","vol":"0.22"},{"date":"2025-06-30","value":"0.10","vol":"0.14"},{"date":"2025-03-31","value":"0.05","vol":"0.06"},{"date":"2024-12-31","value":"0.18","vol":"0.29"},{"date":"2024-09-30","value":"0.11","vol":"0.22"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.16	0.10	0.05	0.18	0.11
行业(次)	0.22	0.14	0.06	0.29	0.22

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.64","vol":"0.91"},{"date":"2025-06-30","value":"0.41","vol":"0.56"},{"date":"2025-03-31","value":"0.16","vol":"0.26"},{"date":"2024-12-31","value":"0.73","vol":"1.17"},{"date":"2024-09-30","value":"0.59","vol":"0.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.64	0.41	0.16	0.73	0.59
行业(次)	0.91	0.56	0.26	1.17	0.86

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"-2.20","vol":"1.99"},{"date":"2025-06-30","value":"-45.68","vol":"-1377.61"},{"date":"2025-03-31","value":"-4.86","vol":"-46.99"},{"date":"2024-12-31","value":"-47.31","vol":"-11.33"},{"date":"2024-09-30","value":"-51.14","vol":"-30.88"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	-2.20	-45.68	-4.86	-47.31	-51.14
行业	1.99	-1377.61	-46.99	-11.33	-30.88

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.96","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.11","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	1.96	-	2.11	-
行业	0.00	1.59	0.00	2.01	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 3/72 ， 10/72。

[{"date":"2025-09-30","value":"1.62","vol":"5.99"},{"date":"2025-06-30","value":"1.61","vol":"6.64"},{"date":"2025-03-31","value":"1.40","vol":"7.75"},{"date":"2024-12-31","value":"1.72","vol":"6.72"},{"date":"2024-09-30","value":"2.00","vol":"7.02"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	1.62	1.61	1.40	1.72	2.00
行业	5.99	6.64	7.75	6.72	7.02

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.35","vol":"4.82"},{"date":"2025-06-30","value":"1.36","vol":"5.30"},{"date":"2025-03-31","value":"1.13","vol":"6.35"},{"date":"2024-12-31","value":"1.40","vol":"5.40"},{"date":"2024-09-30","value":"1.62","vol":"5.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.35	1.36	1.13	1.40	1.62
行业	4.82	5.30	6.35	5.40	5.66

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 5/72 ， 10/72。

[{"date":"2025-09-30","value":"46.14","vol":"28.14"},{"date":"2025-06-30","value":"45.25","vol":"26.73"},{"date":"2025-03-31","value":"47.98","vol":"26.03"},{"date":"2024-12-31","value":"44.98","vol":"25.81"},{"date":"2024-09-30","value":"42.16","vol":"24.44"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	46.14	45.25	47.98	44.98	42.16
行业(%)	28.14	26.73	26.03	25.81	24.44

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.87","vol":"0.58"},{"date":"2025-06-30","value":"0.83","vol":"1.11"},{"date":"2025-03-31","value":"0.93","vol":"0.78"},{"date":"2024-12-31","value":"0.83","vol":"0.87"},{"date":"2024-09-30","value":"0.74","vol":"0.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.87	0.83	0.93	0.83	0.74
行业(%)	0.58	1.11	0.78	0.87	0.40

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"-7.21","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-23.88","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-22.83","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-12.81","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-7.78","blueLineValue":"-0.76","type":"YC"}]

[君实生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]